|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology (-)2010，，1： | 3 |
| 2 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology . 2010 (1-2)2010，，1： | 2 |
| 3 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology (-)2010，，1： | 1 |
| 4 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology (-)2010，，1： | 1 |
| 5 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology (-)2010，，1： | 1 |
| 6 | HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series显示文摘 | Heike Grabsch Shivan Sivakumar Sally Gray Helmut E. Gabbert Wolfram Müller | 2010 | Cellular Oncology (-)2010，，1： | 1 |
| 7 | Editorial on“Perihilar Cholangiocarcinoma-Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers”显示文摘Cholangiocarcinoma(CCA)is a rare and very aggressive malignancy arising from the biliary tract.Based on the location of the tumor,CCA can be divided in intrahepatic cholangiocarcinoma(iCCA),perihilar cholangiocarcinoma(pCCA)and distal cholangiocarcinoma(dCCA).Many other characteristics differentiate these groups,including pathological features,oncological approach and surgical techniques,which in turn influences patient outcomes. | Shivan Sivakumar Flavio GRocha Lara Heij | 2022 | Hepatobiliary Surgery and Nutrition2022，11，3： | 0 |
| 8 | The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma显示文摘The World Health Organisation(WHO)classifies clinical diagnoses with the International Statistical Classification of Disease and Related Health Problems(ICD).There have been various iterations of ICD since it is inception.For oncology,ICD-O was introduced in 1976 as a special adaption of ICD for cancers to facilitate greater coding detail of the topography,which describes the anatomical location of the tumour origin,and the morphology concerns the histology of a neoplasm.ICD-10 began in 1983 and was first used in 1994.At the same time,a code for cholangiocarcinoma(CCA)was also introduced(http://gffzzbc7f942e37084265sx9c90nuuvfbc6vuw.ffgz.tsg.suse.edu.cn/browse10/2010/en). | Shijie Cai Shivan Sivakumar | 2022 | Hepatobiliary Surgery and Nutrition2022，11，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员